… introduced antibody and vaccine countermeasures. Here, using monoclonal antibodies (…
, we report the impact on antibody neutralization of a panel of authentic SARS-CoV-2 variants …

… by polyclonal antibodies in individuals who are SARS-CoV-2 … with vesicular stomatitis
virus/SARS-CoV-2 chimaeras 5 , here … , are variably targeted by human polyclonal antibodies. …

… Here, using monoclonal antibodies (mAbs), animal immune … on antibody neutralization of a
panel of authentic SARS-CoV-2 … We also noted that cell line selection used for growth of virus …

… documented benefits of polyclonal antibodies in applications … In terms of the emerging
SARS-CoV-2 strains — N501Y in … polyclonal antibodies to N protein to detect SARS-CoV-2. Even …

… -targeting polyclonal response by a single antibody class is a major factor in enabling a small
number of viral mutations to sometimes substantially erode neutralizing antibody immunity. …

… of polyclonal plasma Fabs, revealing recognition of both S1 A and RBD epitopes on SARS-CoV-2
… SARS-CoV-2 spike mutations. Overall, our studies structurally define a recurrent anti-…

… A substantial fraction of the neutralizing activity of polyclonal antibody response to SARS-CoV-2
infection is due to antibodies that target the RBD 17,18,19,20,21 , although …

… Heterologous polyclonal antibodies might represent an … or monoclonal antibodies (mAbs)
in coronavirus disease (… , heterologous antibodies trigger human natural xenogeneic antibody …

… immune reactivity of human monoclonal antibody made against SARS-CoV-2 spike protein
and nucleoprotein and rabbit polyclonal antibody made against SARS-CoV-2 envelope and …

… In this study, we found two peptide-induced antibodies against spike protein and polyclonal
antibodies against nucleocapsid protein could specifically recognize SARS-CoV infected …